0ACH
Sign in
MedinCell
Save
–
Market cap
–
Current P/E
–
Forward P/E
About
MedinCell S. A., a pharmaceutical company, develops long acting injectables in various therapeutic areas in France. It develops solutions based on BEPO, a long-acting injectable technology; and offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults.
Similar securities
Based on sector and market capitalization
Report issue